INCY.NASDAQIncyte CORP

Form 4: Incyte EVP & General Counsel Executes Pre-Planned Stock Option Exercise and Sale

Sentiment:

Insider Transaction Report


Incyte Corporation's Executive Vice President and General Counsel, Sheila A. Denton, engaged in a pre-planned transaction involving the exercise of stock options and the subsequent sale of common stock on July 2, 2025.

Summary

  • Sheila A. Denton, Executive Vice President and General Counsel of Incyte Corp (INCY), executed a pre-planned transaction under a Rule 10b5-1(c) plan on July 2, 2025.
  • The transaction involved the exercise of employee stock options to acquire 599 shares of common stock at an exercise price of $58.06 per share.
  • Concurrently, 599 shares of common stock were sold at a price of $68.61 per share.
  • Following these transactions, Denton's direct beneficial ownership of common stock is 26,504 shares, which includes an aggregate of 25,848 shares issuable pursuant to previously reported unvested restricted stock units and earned performance units.
  • Denton also holds 16,158 unexercised employee stock options with an exercise price of $58.06, which began vesting on October 2, 2023, with the first 25% vesting on October 2, 2024, and the remainder vesting monthly over three years.

Sentiment

Score: 5

Explanation: The filing details a routine, pre-planned insider transaction (option exercise and sale) which is common for executive compensation and personal financial management. It does not indicate any significant positive or negative developments for the company's operations or financial health.

Positives

  • The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary transaction, which can reduce concerns about insider trading.
  • The sale price of $68.61 per share is higher than the exercise price of $58.06, indicating a gain on the exercised options.

Negatives

  • The sale of 599 shares by an executive reduces their direct equity stake in the company, although this is a common practice for liquidity or tax purposes following option exercise.

Future Outlook

NA

Industry Context

This is a routine insider transaction (Form 4) and does not provide broader industry context. It reflects an individual executive's compensation and personal financial planning rather than company-wide strategic or operational developments.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure PracticeThe transaction was made pursuant to a Rule 10b5-1(c) plan, which is a pre-arranged trading plan designed to provide an affirmative defense against insider trading allegations.2025-07-02Enhances transparency and demonstrates adherence to best practices for insider trading compliance by pre-scheduling transactions.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, pre-planned transaction by an executive for personal financial management. It does not signal a change in company fundamentals.
  • Employees: No direct impact.
  • Customers: No direct impact.
  • Suppliers: No direct impact.
  • Creditors: No direct impact.

Next Steps

  • Continued vesting of remaining employee stock options according to the established schedule.

Key Dates

DateDescription
2023-10-02Date when employee stock options began to become exercisable.
2024-10-02Date when the first 25% of employee stock options vested.
2025-07-02Date of the reported stock option exercise and sale transactions.
2025-07-07Date the Form 4 was signed by the Attorney-In-Fact.
2033-10-02Expiration date of the employee stock options.

Keywords

Incyte Corp, INCY, SEC Form 4, insider trading, stock options, executive compensation, Sheila A. Denton, Rule 10b5-1, common stock, share sale, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.